Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Injectable platelet-rich fibrin for shoulder osteoarthritis
RBR-7gr7655Recruiting
- Sponsor
- Hospital Universitário Pedro Ernesto
- Start
- Jun 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of platelet rich fibrin, triamcinolone and lidocaine in glenohumeral osteoarthritis and rotator cuff arthropathy (CTA) (2 arms), sponsored by Hospital Universitário Pedro Ernesto. Started Jun 2024; status: recruiting.
02
Drugs
platelet rich fibrintriamcinolonelidocaine
03
Conditions
glenohumeral osteoarthritisrotator cuff arthropathy (CTA)
Beyond the preview
Go deeper on RBR-7gr7655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-7gr7655.